Professor Daniel Altmann
Imperial College London, UK
Professor Altmann is Professor of Immunology at Imperial College London. His key research interests are the immunology of infectious disease including severe bacterial infections, Zika virus and Chikungunya virus. Other projects focus on autoimmune disease including the role of the microbiota in rheumatoid arthritis and autoimmune immunotoxicity in cancer immunotherapy. Professor Altmann’s expertise includes the HLA system, antigen discovery, T cell subsets and NK cells. He has been a key figure in building the NIH Immune Epitope Database, an open-access database of pathogen epitopes, and has extensive Editorial experience on a number of journals. He spent a number of years working on strategy in infection, immunity and population health at the Wellcome Trust, and is a trustee of the MRC Medical Research Foundation, and a BBSRC panel member.
Dr Rachael Bashford-Rogers
Wellcome Trust Centre for Human Genetics, University of Oxford, UK
Dr Bashford-Rogers is a principle investigator at the Wellcome Trust Centre for Human Genetics, University of Oxford, having been a Sir Henry Wellcome Post-doctoral Fellow and a Jesus College Research Fellow at the University of Cambridge, and PhD at the Wellcome Sanger Institute. Dr Bashford-Rogers’ lab is developing and exploiting the latest technologies of single-cell sequencing, imaging, B/T cell receptor repertoire analyses, functional methods and computational analyses to explore the basis of immune regulation and effects of therapies across autoimmunity, cancer, immunodeficiencies, and infectious diseases.
Dr Daniel Douek
National Institutes of Health, USA
Dr. Douek is the Chief of the Human Immunology Section, Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, USA. Dr. Douek studied medicine at the Universities of Oxford and London. He then practiced internal medicine, before pursuing a PhD in Immunology at the University of London. Currently, the main focus of his laboratory is the pathogenesis of HIV infection. Dr. Douek was given the World AIDS Day Award in 2007, the NIH Director’s Award in 2008. He was named as one of the 2012 POZ 100 for his significant contributions to accelerating the end of AIDS.
Professor Hongyang Wang
Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China
Professor Wang was trained in Anhui Medical University, China and Imperial College London, UK. She then worked as Research Fellow in University of Cambridge, UK and was appointed as a PI in SIBCB, CAS, China since year 2010. Her research interest is to find new kinases or enzymes as drug targets in macrophage or CD8+ T cell against infection and tumor. As a corresponding author, she has published about 20 articles, including identification of several effectors in the regulation of inflammatory cytokines or interferon production against infections. Professor Wang is an Editors for a number of journals in the field of immunology.
Editorial Advisory Board
Rosemary Boyton, Imperial College London, UK
Amy Chung, University of Melbourne, Australia
Katie Ewer, University of Oxford, UK
Victoria Male, Imperial College London, UK
Faith Osier, Heidelberg University and KEMRI Wellcome Trust, Germany and Kenya
Gosia Trynka, Wellcome Sanger Institute, UK